Despite setbacks in DME, Adverum Biotechnologies said it will continue to develop ADVM-022 for wet AMD.
Victoria Johnson
Advertisement
Articles by Victoria Johnson
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Modern Retina
1
Avacincaptad pegol analysis links GA treatment to preserved driving vision
2
Tinlarebant earns Swiss orphan drug status for Stargardt disease
3
QA102 data suggest signal in intermediate dry AMD, but insignificant drusen volume change
4
No 'smoking gun' OCT biomarker found for DME outcomes: Insights from Protocol T
5